Lv1
40 积分 2024-01-02 加入
A disproportionality analysis of thromboembolic and cardiovascular adverse event signal strength across various JAK-inhibitors based on the FAERS database
2个月前
已完结
Anticoagulation Regimens in Pregnancy
2个月前
已完结
Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database
2个月前
已完结
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
2个月前
已完结
Development of new anticoagulants targeting coagulation factor XI and prospects for clinical use
2个月前
已完结
The effectiveness and safety of administering antiplatelet medications following reperfusion therapy in patients with ischemic stroke
2个月前
已完结
Fibrinolytic Therapy for Thromboembolic Diseases
2个月前
已完结
Fibrinolytic drugs induced hemorrhage: mechanisms and solutions
2个月前
已完结
Antithrombotic drugs in secondary stroke prevention: still some way to go
2个月前
已完结
Mechanisms of thrombosis and research progress on targeted antithrombotic drugs
2个月前
已完结
皖公网安备34019202002308
